EYE 1.92% 26.5¢ nova eye medical limited

Ann: 2RT Post LEAD Review Shows Improved Treatment Benefits, page-35

  1. 7,078 Posts.
    lightbulb Created with Sketch. 1063
    No doubt about that @TheAnalyst007 & interesting to compart EYE with OPT, laser vs drug intervention for AMD, admittedly OPT Opthea are targeting a 'cure' for late stage wet AMD vs EYE trying to prevent the progression to advanced wet AMD in the first place, so a different target market & less super expressive ongoing drug treatment.

    BUT market cap comparison is interesting:

    EYE MC A$50 Mil - A$30 Mil in cash in the bank, no debt = EV approx A$20 Mil !! ,revenue A$6.644,000 loss (A$1,605,000) as at Feb 2021 half yr report

    OPT MC A$500 Mil - A$202,544,985 cash, no debt = EV approx A$300 Mil ,revenue A$314,294 loss (A$34,982,213) as at Feb 2021 half yr report

    So roughly OPT chasing the same market with no revenue like iTrack business, has MC approx 15x greater than EYE

    EYE has some room to move up IMO !!
    https://hotcopper.com.au/data/attachments/2975/2975662-eb4805af241f553fafeac0c0f27748e1.jpg
    .

    Last edited by hatmopit: 06/03/21
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
26.5¢
Change
0.005(1.92%)
Mkt cap ! $60.63M
Open High Low Value Volume
26.0¢ 27.0¢ 26.0¢ $65.13K 246.1K

Buyers (Bids)

No. Vol. Price($)
7 182723 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.5¢ 39014 1
View Market Depth
Last trade - 16.10pm 07/05/2024 (20 minute delay) ?
Last
26.0¢
  Change
0.005 ( 0.00 %)
Open High Low Volume
26.5¢ 27.5¢ 26.0¢ 118919
Last updated 15.59pm 07/05/2024 ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.